Triple Negative Breast Cancer Whole Blood
About: Whole blood from donors with confirmed triple negative breast cancer (TNBC). Useful for BRCA1/2 analysis and liquid-biopsy research.
<h2>Triple Negative Breast Cancer Whole Blood for Research</h2>
Triple negative breast cancer (TNBC) lacks estrogen, progesterone, and HER2 receptor expression, making it more aggressive and reliant on chemotherapy and emerging immunotherapy approaches. Sanguine collects fresh whole blood from IRB-consented donors with a clinically confirmed TNBC diagnosis for oncology biomarker research.
<h3>Product Features</h3>
<ul><li>Fresh whole blood from clinically diagnosed TNBC donors</li><li>Custom anticoagulants and collection tubes available</li><li>Same-day collection and shipment</li><li>Research Use Only (RUO)</li></ul>
<h3>De-identified Donor Data</h3>
<ul><li>Physician-confirmed TNBC diagnosis, including BRCA status where available</li><li>Demographics: age, sex assigned at birth, ethnicity</li><li>Relevant medical and treatment history</li></ul>
<h3>Applications</h3>
<ul><li>BRCA1/2 and genomic risk-variant analysis</li><li>Circulating tumor DNA and liquid-biopsy studies</li><li>Gene expression and transcriptomic analysis</li><li>Immunotherapy and chemotherapy response research</li></ul>
<h3>Compliance and Quality</h3>
<ul><li>IRB-approved protocols and electronic informed consent</li><li>HIPAA-compliant donor data handling</li></ul>
<h3>Ordering and Customization</h3>
TNBC whole blood is available in standard and custom volumes. Email <a href=”mailto:learnmore@sanguinebio.com”>learnmore@sanguinebio.com</a> for international orders or documentation requirements.
Whole Blood
Frequently Asked Questions
1 Answer
All our samples have self-reported infectious disease testing and verified clinical diagnosis. Many of our samples have the option of electronic medical records provided and our prospective collection offers the opportunity for patient reported outcomes and surveys. Learn more here. https://sanguinebio.com/patient-reported-outcomes-pro-surveys-questionnaires/
1 Answer
YES – Certificate of analysis is available upon request.
1 Answer
Lead times vary from ready to ship inventory to prospective studies.
1 Answer
International shipping is available. We also work with a number of distributors. Contact us to discuss options at learnmore@sanguinebio.com.
1 Answer
We have several ordering methods. You can order directly online with a PO or credit card or contact us to have a sales specialist help with your order. https://sanguinebio.com/request-quote/
1 Answer
You can request a quote on this page or contact us at learnmore@sanguinebio.com. https://sanguinebio.com/request-quote/
1 Answer
NO – no minimum order requirements.
1 Answer
For bulk pricing inquiries, please contact: LearnMore@sanguinebio.com
1 Answer
YES, in some cases we can accomodate this request including treatment naive oncology samples. As we have electronic medical records, we can also accomodate specific treatment regiments.
1 Answer
YES – Donor metadata includes: gender, race/ethnicity, age, medications, healthcare encounters, and more. To learn more visit https://sanguinebio.com/donor-data/
1 Answer
Custom volumes available – The website consistently mentions “custom volumes” are available. You should contact learnmore@sanguinebio.com to discuss specific volume requirements and multiple units from the same donor.
1 Answer
Sanguine offers same-day delivery in many metropolitan areas. Whole Blood ships same day with next-day delivery options available. For more information, request a quote or contact: LearnMore@sanguinebio.com
Ask a Question
Need a custom Whole Blood cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.